Case Western Reserve University researchers have discovered a novel population of neutrophils, which are the body’s infection control workhorses. These cells have an enhanced microbial killing ability and are thereby better able to control infection.
Uncategorized
FDA clears 532 nm laser for Stellaris system
The Stellaris PC Vision Enhancement System has received 510(k) clearance from the U.S. Food and Drug Administration for the integrated 532 nm green laser and software, Bausch + Lomb announced in a press release. The laser can be upgraded for existing S…
Uncategorized
OD-OS introduces Navilas Laser System 577+
The Navilas Laser System 577+ will be launched at the World Ophthalmology Congress in Tokyo, OD-OS announced in a press release. The laser system features a yellow 577 nm wavelength and microsecond pulsed laser treatments.
Uncategorized
New cross-linking protocol, device may help fight infectious keratitis on a global scale
LISBON, Portugal — An optimized treatment protocol, a miniaturized device that mounts on a slit lamp and a new photosensitizing agent may allow for a faster and more effective application of cross-linking for infectious keratitis in the near future. Cross-linking for infectious keratitis, now called PACK-CXL for photoactivated chromophore for keratitis-CXL, disinfects the corneal surface via reactive oxygen species and increases the resistance to enzymatic digestion by modification of the collagen structure.
Uncategorized
Cost, accessibility remain issues for homebased monitoring of AMD
LISBON, Portugal — Daily home-based monitoring of age-related macular degeneration can have a positive impact on prompt, early treatment and preservation of vision, but access and cost may be issues, speakers said during a debate at the Controversies in Ophthalmology meeting. Susan B. Bressler, MD, PhD, presented results of the National Eye Institute’s HOME study, a secondary study to AREDS2, in which the ForeseeHome AMD Monitoring Program (Notal Vision) was used. The study was a 3-year phase 3 trial in which 1,520 participants were randomized 1:1 into the device group (Read more...)
Uncategorized
Under-monitoring, under-treatment of AMD confirmed by real-life studies
LISBON, Portugal — Real-life studies carried out in different countries confirmed that age-related macular degeneration patients who require intravitreal anti-VEGF injections are under-monitored and under-treated. “Several studies already published, including LUMIERE, AURA, WAVE and Coimbra, as well as Medicare data, seem to indicate that this is the scenario all over the world,” Rufino Silva, MD, said at the Controversies in Ophthalmology meeting. The studies looked at the results of real-world clinical practice and revealed a scenario that is different from what should be expected by following the recommendations of clinical (Read more...)